
|Articles|August 28, 2014
- Head and Neck Cancers (Issue 1)
- Volume 1
- Issue 1
Immunotherapy in Head and Neck Cancers
Author(s)Ezra Cohen, MD
Ezra Cohen, MD, professor of medicine, UC San Diego Moores Cancer Center, discusses immunotherapy in head and neck cancer.
Advertisement
Ezra Cohen, MD, professor of medicine, UC San Diego Moores Cancer Center, discusses immunotherapy in head and neck cancer.
View more about novel approaches to the treatment of head and neck cancers > >
Articles in this issue
over 11 years ago
Unmet Needs in the Treatment of Thyroid Cancerover 11 years ago
Molecular Markers Emerge in the Diagnosis of Thyroid Cancerover 11 years ago
Results of the SELECT Trial in Thyroid Cancerover 11 years ago
Update on Targeted Therapies in Head and Neck CancersAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5



















